Who is sponsoring NCT04167644?

NCT04167644 is sponsored by Mansoura University Hospital.

What drugs are being tested in NCT04167644?

Interventions in NCT04167644: Modified Rankin Scale (mRS).

What condition does NCT04167644 study?

NCT04167644 studies Intra Cerebral Hemorrhage, Hypertension.

Is NCT04167644 still recruiting?

NCT04167644 is currently completed. Last updated 3 December 2019.

Last reviewed 2019-12-03 · How we verify

NCT04167644

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proper Timing of Control of Hypertension and Outcome in Acute Spontaneous Intracerebral Hemorrhage.

Completed Last updated 3 December 2019

What this trial tests

trial testing Modified Rankin Scale (mRS) in Intra Cerebral Hemorrhage in 150 participants. Completed in 1 April 2019.

Timeline

1 May 2018

Primary endpoint
1 March 2019

1 April 2019

Quick facts

Lead sponsor	Mansoura University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 May 2018
Primary completion	1 March 2019
Estimated completion	1 April 2019
Sites	1 location across Egypt

Drugs / interventions tested

Modified Rankin Scale (mRS)

Conditions studied

Intra Cerebral Hemorrhage — all drugs for Intra Cerebral Hemorrhage →
Hypertension — all drugs for Hypertension →

Sponsor

Mansoura University Hospital

Who can join

25 and older, any sex, with Intra Cerebral Hemorrhage or Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ideal management of blood pressure in BP after acute intracerebral haemorrhage is still debated and whether a higher intensive reduction of blood pressure after acute intracerebral haemorrhage may be better or not is still controversial. Conflicting results from different randomized trials in regards to the clinical guidelines for management of hypertension in people with acute intracerebral hemorrhage (ICH). These results indicate that the management of BP and the prognosis after acute spontaneous ICH are very complicated. Therefore, analysis based on actual blood pressure (BP) accomplished may be a more efficient method to assess the impact of BP management on outcome of ICH. In our research, blood pressure (BP) management and prognosis were studied in patients with acute intracerebral hemorrhage to decide the perfect time control BP to improve outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Modified Rankin Scale (mRS)

Trials testing the same drug.

NCT07336992 — Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: · Phase 3 · not yet recruiting

Other recruiting trials for Intra Cerebral Hemorrhage

Currently open trials in the same condition.

NCT06383741 — Predicting Outcomes in ICH Patients on Direct Factor Xa Inhibitors · recruiting
NCT03990558 — Recovery of Consciousness Following Intracerebral Hemorrhage · recruiting

Other Mansoura University Hospital trials

Trials by the same sponsor.

NCT05936528 — Lactoferrin Use in ICU Patients · Phase 4 · not yet recruiting
NCT07442617 — Bridging the Gap Between Prescription and Practice: Impact of Nurse-Led Inhaler Education · NA · completed
NCT07422415 — Effects of E-Cigarette Use Among Young Egyptian Adults · completed
NCT07122245 — Demographics of Lung Cancer in Females · recruiting
NCT06917222 — Slide Tracheoplasty Versus Tracheal Resection Anastomosis in Acquired Tracheal Stenosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04167644 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University Hospital
Last refreshed: 3 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04167644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing